Return
Multimodal biomarker AI techniques for early neurocognitive disorder diagnosis: A systematic review
F
F
R
V
L
A
F
G
G
C
G
D
Y
R
DOI:10.1016/j.artmed.2026.103389.png)
Abstract
En 中文
• Multimodal AI improves early AD/MCI detection over single-modality models. • Typical AUC gains: ~0.75–0.88 to ~0.85–0.95 with multimodal integration. • Most studies lacked external validation and used homogeneous datasets. • Emerging modalities (e.g., retina + plasma) show strong early-stage signal. • Clinical adoption needs fairness assessment and stronger model interpretability.
Keywords:
Multimodal AI
early detection
neurocognitive disorders
biomarkers
model interpretability
Journal
IF:
6.2
Papers:
2.5K
Citations:
7.8K
